Telomerase-Directed Molecular Therapeutics

Keith, W.N. , Bilsland, A., Evans, T.R.J. and Glasspool, R.M. (2002) Telomerase-Directed Molecular Therapeutics. Expert Reviews in Molecular Medicine(4), pp. 1-25. (doi:10.1017/S1462399402004507)

Keith, W.N. , Bilsland, A., Evans, T.R.J. and Glasspool, R.M. (2002) Telomerase-Directed Molecular Therapeutics. Expert Reviews in Molecular Medicine(4), pp. 1-25. (doi:10.1017/S1462399402004507)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1017/S1462399402004507

Abstract

The management of malignant disease remains one of the most challenging areas of modern medicine. The lifetime risk of developing cancer in the western world is estimated to be as high as 1 in 3. Traditionally, surgery, chemotherapy and radiotherapy have been the primary choice of treatment for patients with malignant tumours. Despite advances in the use and development of conventional cytotoxic agents, the cure rate remains disappointing in most patients with advanced disease of the common solid tumours. Consequently, the development of novel anti-cancer therapies is a high priority in cancer medicine. In recent years, a new generation of cancer therapies has emerged, based on a growing understanding of the molecular events that contribute to malignant transformation. A major difference between normal and cancer cells is the ability of cancer cells to multiply in an unrestricted and ungoverned fashion. In this context, there is considerable interest in elucidating the mechanisms that allow this unrestricted proliferation and that ultimately result in immortal cancer cells. It is now clear that the enzyme telomerase confers immortality on cells in most types of cancer. With the cancer cell reliant on telomerase for its survival, telomerase represents an extremely attractive mechanism-based target for the development of new cancer therapeutics.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Keith, Professor Nicol and Evans, Professor Thomas and Bilsland, Dr Alan
Authors: Keith, W.N., Bilsland, A., Evans, T.R.J., and Glasspool, R.M.
Subjects:R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RB Pathology
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:Expert Reviews in Molecular Medicine
ISSN:1462-3994

University Staff: Request a correction | Enlighten Editors: Update this record